#MENOPAUSE

The North American Menopause Society (NAMS) recently released updated menopause hormone therapy guidelines, and we are eager to share with you what has changed.
Are you:
In your fifties and having difficult symptoms like hot flashes, insomnia, or mood changes?
In your 20’s or 30’s finding yourself in early menopause from Premature Ovarian Insufficiency (POI)?
Experiencing vaginal dryness, painful sex and/or urinary leaks but don’t know what your options are because you are a breast cancer survivor or have a family history of breast cancer?
In late perimenopause and wondering if you should go on hormone therapy once you reach menopause?
Taking hormones and wondering if you need to stop taking them?
The new NAMS guidelines address these situations and more. They are worth understanding because NAMS, a nonprofit medical society whose members include experts across the medical professions, is known as the leading evidence-based resource on midlife women’s health and menopause.
Two practitioners, researchers, and leaders in the menopause field-Dr. Jewel Kling and Dr. Paru David, both from the Mayo Clinic-will address how the guideline changes will affect millions of women and the confusions many of us have. They will leave ample time to answer your questions, so come prepared! The more we know, the better we can navigate our healthcare in mid-life and well beyond.
About the Speakers
Juliana (Jewel) Kling, MD MPH NCMP FACP (She/her/hers)
Professor of Medicine, Chair of Women’s Health Internal Medicine, Associate Chair of Equity, Inclusion and Diversity, Department of Medicine, Mayo Clinic Arizona
Dr. Jewel Kling is a Professor of Medicine, Chair of the Division of Women’s Health Internal Medicine, Assistant Director of the Women’s Health Center and Associate Chair of Equity, Inclusion and Diversity for the Department of Medicine at the Mayo Clinic in Scottsdale, Arizona. She completed medical school and a master’s in public health at the University of Arizona Tucson and Internal Medicine Residency at Mayo Clinic Arizona, followed by a Chief Internal Medicine fellowship year. Her clinical and research interest are in menopause, sexual health, and LGBT care. She is a North American Menopause Society (NAMS) Certified Menopause Practitioner and serves on the board of the International Society for the Study of Women’s Sexual Health (ISSWSH), and the American Medical Women’s Association Sex and Gender Health Collaborative. She is part of the transgender steering committee at Mayo Clinic Arizona and has been a past co-chair of the LGBTI Mayo Employee Resource Group. She is also involved in education and is active with the Internal Medicine residency and Mayo Clinic Alix School of Medicine, as well as efforts to expand the discipline of Sex and Gender specific medicine.
Dr. Paru David, MD, NCMP, FACP (She/her/hers)
Assistant Professor of Medicine, Women’s Health Internal Medicine, Block Leader-Basic Doctoring Mayo Clinic Alix School of Medicine, Mayo Clinic Arizona
Dr. Paru David is an Assistant Professor of Medicine at Mayo Clinic. She received her medical degree at University of Missouri, Kansas City after completing a combined BA/MD program in 6 years. After her Internal Medicine residency at Banner University Medical Center in Phoenix, Arizona, she joined Women’s Health Internal Medicine at Mayo Clinic in 1999. She has been a Fellow of the American College of Physicians since 2006 and a North American Menopause Society Certified Menopause Practitioner since 2003. She provides primary care to women as well as consultative care in the areas of menopause, contraception, and sexual health. She is also involved in education and is Block Leader for the Basic Doctoring course at Mayo Clinic Alix School of Medicine.
*******************************
Special thanks to Alloy for sponsoring Menopause Talks.
Let's Talk Menopause is a nonprofit organization in partnership with Revel to produce these Menopause Talks.
*MEDICAL ADVICE DISCLAIMER: All Menopause Talks are intended for informational purposes only, not as a substitute for professional medical advice, diagnosis, or treatment. Reliance on any of this information is solely at your own risk. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new healthcare regimen. Never disregard professional medical advice or delay seeking advice because of something you have read here.

[@DW...]

Every cell in our bodies has estrogen - but postmenopause we will become zero - I was told bhrt can benefit with brain health, heart attacks, bone density & more so why did you not discuss that?

[@lf7065]

Love these chats! TY!

[@letstalkmenopause]

So glad!

[@nursesona7227]

Is risk of breast cancer with HRT ( 1/1000) from oral or vaginal HRT?

[@letstalkmenopause]

systemic (oral or transdermal). We are actually doing our Menoapuse Talk in October about local vaginal estrogen and how it differers from Systemic.

[@luciano9376]

✨ p̶r̶o̶m̶o̶s̶m̶